Radioactive seed localization is a safe and effective tool for breast cancer surgery: an evaluation of over 25,000 cases.
D MiodownikD BiermanC ThorntonT MooKimberly N FeiginA DamatoT LeM WilliamsonK PrasadB ChuLawrence Thomas DauerN SaphierP ZanzonicoM MorrowMichael B BellamyPublished in: Journal of radiological protection : official journal of the Society for Radiological Protection (2024)
Radioactive seed localization (RSL) provides a precise and efficient method for removing non-palpable breast lesions. It has proven to be a valuable addition to breast surgery, improving perioperative logistics and patient satisfaction. This retrospective review examines the lessons learned from a high-volume cancer center's RSL program after 10 years of practice and over 25 000 cases. We provide an updated model for assessing the patient's radiation dose from RSL seed implantation and demonstrate the safety of RSL to staff members. Additionally, we emphasize the importance of various aspects of presurgical evaluation, surgical techniques, post-surgical management, and regulatory compliance for a successful RSL program. Notably, the program has reduced radiation exposure for patients and medical staff.
Keyphrases
- quality improvement
- patient satisfaction
- minimally invasive
- coronary artery bypass
- end stage renal disease
- chronic kidney disease
- ejection fraction
- primary care
- newly diagnosed
- surgical site infection
- cardiac surgery
- transcription factor
- peritoneal dialysis
- patients undergoing
- prognostic factors
- squamous cell carcinoma
- percutaneous coronary intervention
- patient reported outcomes
- squamous cell
- long term care
- acute kidney injury
- patient reported
- atrial fibrillation